These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 32144424)
1. Electronic direct-to-consumer advertising of pharmaceuticals: an assessment of textual and visual content of websites. Alkazemi MF; Van Stee SK Health Educ Res; 2020 Apr; 35(2):134-151. PubMed ID: 32144424 [TBL] [Abstract][Full Text] [Related]
2. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites. Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Aikin KJ J Health Commun; 2017 Feb; 22(2):171-181. PubMed ID: 28129069 [TBL] [Abstract][Full Text] [Related]
3. How direct-to-consumer drug websites convey disease information: analysis of stigma-reducing components. Kang H; An S J Health Commun; 2013; 18(12):1477-91. PubMed ID: 24015752 [TBL] [Abstract][Full Text] [Related]
4. Disclosing accelerated approval on direct-to-consumer prescription drug websites. Sullivan HW; O'Donoghue AC; David KT; Patel NJ Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1277-1280. PubMed ID: 30264874 [TBL] [Abstract][Full Text] [Related]
5. Quantitative Information on Oncology Prescription Drug Websites. Sullivan HW; Aikin KJ; Squiers LB J Cancer Educ; 2018 Apr; 33(2):371-374. PubMed ID: 27589969 [TBL] [Abstract][Full Text] [Related]
6. Consumer confusion between prescription drug precautions and side effects. Amoozegar JB; Rupert DJ; Sullivan HW; O'Donoghue AC Patient Educ Couns; 2017 Jun; 100(6):1111-1119. PubMed ID: 28069321 [TBL] [Abstract][Full Text] [Related]
7. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". Mackey TK Int J Health Policy Manag; 2016 Feb; 5(4):271-4. PubMed ID: 27239871 [TBL] [Abstract][Full Text] [Related]
8. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". Doran E Int J Health Policy Manag; 2016 Feb; 5(5):333-5. PubMed ID: 27239884 [TBL] [Abstract][Full Text] [Related]
9. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay. Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746 [TBL] [Abstract][Full Text] [Related]
10. Can online consumers contribute to drug knowledge? A mixed-methods comparison of consumer-generated and professionally controlled psychotropic medication information on the internet. Hughes S; Cohen D J Med Internet Res; 2011 Jul; 13(3):e53. PubMed ID: 21807607 [TBL] [Abstract][Full Text] [Related]
11. Asking a doctor versus referring to the Internet: A comparison study on consumers' reactions to DTC (direct-to-consumer) prescription drug advertising. Jiang P Health Mark Q; 2018; 35(3):209-226. PubMed ID: 30551729 [TBL] [Abstract][Full Text] [Related]
12. Actors in whitespace: Communicating risk information on pharmaceutical websites. O'Donoghue AC; Sullivan HW; Rupert DJ; Fitts Willoughby J; Aikin KJ Health Mark Q; 2019; 36(2):152-167. PubMed ID: 30907290 [TBL] [Abstract][Full Text] [Related]
13. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". Mintzes B Int J Health Policy Manag; 2016 Feb; 5(5):329-31. PubMed ID: 27239883 [TBL] [Abstract][Full Text] [Related]
14. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters. Kim H Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465 [TBL] [Abstract][Full Text] [Related]
15. Is the information "fair and balanced" in direct-to-consumer prescription drug websites? Huh J; Cude BJ J Health Commun; 2004; 9(6):529-40. PubMed ID: 15764451 [TBL] [Abstract][Full Text] [Related]
16. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis. Adams C J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749 [TBL] [Abstract][Full Text] [Related]
17. A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea. Yang YM; Lee JJ; Jeong E; Kim SY; Han MA; Choi EJ PLoS One; 2018; 13(7):e0201108. PubMed ID: 30040833 [TBL] [Abstract][Full Text] [Related]
18. Information versus influence: An analysis of educational, relational, and identity rewards present in direct-to-consumer prescription drug advertising. Applequist J; Hintz EA; Quichocho D; Chesser S; Price D; Sturgess S; Giardino M; Young HN J Am Pharm Assoc (2003); 2021; 61(6):795-803. PubMed ID: 34238672 [TBL] [Abstract][Full Text] [Related]
19. Considering the Future of Pharmaceutical Promotions in Social Media Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". Carpentier FR Int J Health Policy Manag; 2016 Feb; 5(4):283-5. PubMed ID: 27239874 [TBL] [Abstract][Full Text] [Related]
20. Trade Agreements and Direct-to-Consumer Advertising of Pharmaceuticals. Gleeson D; Menkes DB Int J Health Policy Manag; 2018 Feb; 7(2):98-100. PubMed ID: 29524933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]